Celiac Vaccine Phase I Trial Finished
New vaccine for celiac disease finished Phase I trial. The results summary are as follows: 34 test subjects were double blinded to test the safety of the new Nexvax2 vaccine for patients diagnosed with celiac disease. All patients were HLA-DQ 2 or 8 positive. In all, 19 subjects received the vaccine. Three different doses were […]